Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Business of discovering, developing and commercializing therapies derived from or incorporating its2.27M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.27M100.00%